Skip to main content
Advertisement

Main menu

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Special Sections
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Submit
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET

User menu

  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Drug Metabolism & Disposition
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET
  • My alerts
  • Log in
  • My Cart
Drug Metabolism & Disposition

Advanced Search

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Special Sections
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Submit
  • Visit dmd on Facebook
  • Follow dmd on Twitter
  • Follow ASPET on LinkedIn

Table of Contents

August 01, 2003; Volume 31,Issue 8

Short Communications

  • You have access
    DISPOSITION AND METABOLISM OF F6-1α,25(OH)2 VITAMIN D3 AND 1α,25(OH)2 VITAMIN D3 IN THE PARATHYROID GLANDS OF RATS DOSED WITH TRITIUM-LABELED COMPOUNDS
    Setsuko Komuro, Masayuki Sato and Hiroshi Kanamaru
    Drug Metabolism and Disposition August 2003, 31 (8) 973-978; DOI: https://doi.org/10.1124/dmd.31.8.973
  • You have access
    IDENTIFICATION OF CYTOCHROME P450 ENZYMES INVOLVED IN THE METABOLISM OF 4′-METHYL-α-PYRROLIDINOPROPIOPHENONE, A NOVEL SCHEDULED DESIGNER DRUG, IN HUMAN LIVER MICROSOMES
    Dietmar Springer, Liane D. Paul, Roland F. Staack, Thomas Kraemer and Hans H. Maurer
    Drug Metabolism and Disposition August 2003, 31 (8) 979-982; DOI: https://doi.org/10.1124/dmd.31.8.979
  • You have access
    IDENTIFICATION OF A RARE SULFONIC ACID METABOLITE OF ANDROGRAPHOLIDE IN RATS
    Xiangjiu He, Jiankuan Li, Hao Gao, Feng Qiu, Ke Hu, Xiangmin Cui and Xinsheng Yao
    Drug Metabolism and Disposition August 2003, 31 (8) 983-985; DOI: https://doi.org/10.1124/dmd.31.8.983

Articles

  • You have access
    DETECTION OF CARBOXYLIC ACIDS AND INHIBITION OF HIPPURIC ACID FORMATION IN RATS TREATED WITH 3-BUTENE-1,2-DIOL, A MAJOR METABOLITE OF 1,3-BUTADIENE
    Christopher L. Sprague and Adnan A. Elfarra
    Drug Metabolism and Disposition August 2003, 31 (8) 986-992; DOI: https://doi.org/10.1124/dmd.31.8.986
  • You have access
    GLUCURONIDATION AND EXCRETION OF NONYLPHENOL IN PERFUSED RAT LIVER
    Tomo Daidoji, Hiroki Inoue, Seiyu Kato and Hiroshi Yokota
    Drug Metabolism and Disposition August 2003, 31 (8) 993-998; DOI: https://doi.org/10.1124/dmd.31.8.993
  • You have access
    SUBSTITUENT EFFECT ON THE REDUCTIVE N-DEARYLATION OF 3-(INDOL-1-YL)-1,2-BENZISOXAZOLES BY RAT LIVER MICROSOMES
    Richard A. Tschirret-Guth and Harold B. Wood
    Drug Metabolism and Disposition August 2003, 31 (8) 999-1004; DOI: https://doi.org/10.1124/dmd.31.8.999
  • You have access
    IN VITRO DRUG INTERACTIONS OF CYTOCHROME P450: AN EVALUATION OF FLUOROGENIC TO CONVENTIONAL SUBSTRATES
    Lawrence H. Cohen, Michael J. Remley, David Raunig and Alfin D. N. Vaz
    Drug Metabolism and Disposition August 2003, 31 (8) 1005-1015; DOI: https://doi.org/10.1124/dmd.31.8.1005
  • You have access
    MOLECULAR CLONING AND PHARMACOLOGICAL CHARACTERIZATION OF RAT MULTIDRUG RESISTANCE PROTEIN 1 (MRP1)
    Kenichi Nunoya, Caroline E. Grant, Dawei Zhang, Susan P. C. Cole and Roger G. Deeley
    Drug Metabolism and Disposition August 2003, 31 (8) 1016-1026; DOI: https://doi.org/10.1124/dmd.31.8.1016
  • You have access
    GLUCURONIDATION OF HMR1098 IN HUMAN MICROSOMES: EVIDENCE FOR THE INVOLVEMENT OF UGT1A1 IN THE FORMATION OF S-GLUCURONIDES
    Brian T. Ethell, Jens Riedel, Heinrich Englert, Herbert Jantz, Raymond Oekonomopulos and Brian Burchell
    Drug Metabolism and Disposition August 2003, 31 (8) 1027-1034; DOI: https://doi.org/10.1124/dmd.31.8.1027
  • You have access
    COMPARISON OF PRIMARY HUMAN HEPATOCYTES AND HEPATOMA CELL LINE HEPG2 WITH REGARD TO THEIR BIOTRANSFORMATION PROPERTIES
    Stefan Wilkening, Frank Stahl and Augustinus Bader
    Drug Metabolism and Disposition August 2003, 31 (8) 1035-1042; DOI: https://doi.org/10.1124/dmd.31.8.1035
  • You have access
    KIIV, AN IN VIVO PARAMETER FOR PREDICTING THE MAGNITUDE OF A DRUG INTERACTION ARISING FROM COMPETITIVE ENZYME INHIBITION
    John M. Neal, Kent L. Kunze, René H. Levy, Robert A. O'Reilly and William F. Trager
    Drug Metabolism and Disposition August 2003, 31 (8) 1043-1048; DOI: https://doi.org/10.1124/dmd.31.8.1043
  • You have access
    ROLES OF HUMAN CYP2A6 AND 2B6 AND RAT CYP2C11 AND 2B1 IN THE 10-HYDROXYLATION OF (–)-VERBENONE BY LIVER MICROSOMES
    Mitsuo Miyazawa, Atsushi Sugie and Tsutomu Shimada
    Drug Metabolism and Disposition August 2003, 31 (8) 1049-1053; DOI: https://doi.org/10.1124/dmd.31.8.1049
  • You have access
    A TRANSGENIC MOUSE MODEL WITH A LUCIFERASE REPORTER FOR STUDYING IN VIVO TRANSCRIPTIONAL REGULATION OF THE HUMAN CYP3A4 GENE
    Weisheng Zhang, Anthony F. Purchio, Kevin Chen, Jianming Wu, Li Lu, Richard Coffee, Pamela R. Contag and David B. West
    Drug Metabolism and Disposition August 2003, 31 (8) 1054-1064; DOI: https://doi.org/10.1124/dmd.31.8.1054
  • You have access
    DEGRADATION OF GINSENOSIDES IN HUMANS AFTER ORAL ADMINISTRATION
    Mona Abdel Tawab, Ute Bahr, Michael Karas, Mario Wurglics and Manfred Schubert-Zsilavecz
    Drug Metabolism and Disposition August 2003, 31 (8) 1065-1071; DOI: https://doi.org/10.1124/dmd.31.8.1065

Letter to the Editor

  • You have access
    CYP1A1-MEDIATED ACTIVATION OF THALIDOMIDE AND SUPPRESSION OF EMBRYO FIBROBLAST PROLIFERATION
    Shufeng Zhou
    Drug Metabolism and Disposition August 2003, 31 (8) 1072; DOI: https://doi.org/10.1124/dmd.31.8.1072
Back to top
PreviousNext

In this issue

Drug Metabolism and Disposition: 31 (8)
Drug Metabolism and Disposition
Vol. 31, Issue 8
1 Aug 2003
  • Table of Contents
  • About the Cover
  • Index by author
Sign up for alerts

Jump to

  • Short Communications
  • Articles
  • Letter to the Editor
  • Most Read
Loading
  • Cannabinoid Metabolites as CYP450 Inhibitors
  • Physiology of the Neonatal Gastrointestinal System
  • Pharmacokinetics and Disposition of Biologics
  • Switch from CAR to PXR in the Presence of EGF
  • Alternative P450 Splicing Redirects Human Drug Metabolism
More...
Advertisement
  • Home
  • Alerts
Facebook   Twitter   LinkedIn   RSS

Navigate

  • Current Issue
  • Fast Forward by date
  • Fast Forward by section
  • Latest Articles
  • Archive
  • Search for Articles
  • Feedback
  • ASPET

More Information

  • About DMD
  • Editorial Board
  • Instructions to Authors
  • Submit a Manuscript
  • Customized Alerts
  • RSS Feeds
  • Subscriptions
  • Permissions
  • Terms & Conditions of Use

ASPET's Other Journals

  • Journal of Pharmacology and Experimental Therapeutics
  • Molecular Pharmacology
  • Pharmacological Reviews
  • Pharmacology Research & Perspectives
ISSN 1521-009X (Online)

Copyright © 2022 by the American Society for Pharmacology and Experimental Therapeutics